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Abstract 
Decreased drug accumulation is a common cause of antibiotic resistance in microorganisms. 
However, there are few reliable general techniques capable of quantifying drug uptake through 
bacterial membranes. We present a semi-quantitative optofluidic assay for studying the uptake of 
autofluorescent drug molecules in single liposomes. We studied the effect of the Escherichia coli 
outer membrane channel OmpF on the accumulation of the fluoroquinolone antibiotic, norfloxacin, 
in proteoliposomes. Measurements were performed at pH 5 and pH 7, corresponding to two 
different charge states of norfloxacin that bacteria are likely to encounter in the human 
gastrointestinal tract. At both pH values, the porins significantly enhance drug permeation across 
the proteoliposome membranes. At pH 5, where norfloxacin permeability across pure 
phospholipid membranes is low, the porins increase drug permeability by 50-fold on average. We 
estimate a flux of about 10 norfloxacin molecules per second per OmpF trimer in the presence of 
a 1 mM concentration gradient of norfloxacin. We also performed single channel 
electrophysiology measurements and found that the application of transmembrane voltages 
causes an electric field driven uptake in addition to concentration driven diffusion. We use our 
results to propose a physical mechanism for the pH mediated change in bacterial susceptibility to 
fluoroquinolone antibiotics. 
 
 
 
 
 
 
 
 
  
Introduction 
Antimicrobial resistance is a daunting challenge, threatening to undermine the very fabric of 
modern medicine today1-4. The inexorable emergence of resistant organisms, coupled with a 
decline in the discovery of new antimicrobials, has led to a global public health crisis. The recent 
breakthrough discovery of a new antibiotic, teixobactin5, is extremely good news. However, its 
relative inactivity against Gram-negative pathogens shows that the battle against antimicrobial 
resistance will be extremely challenging.  
Gram-negative bacteria have a hydrophobic double-membrane cell envelope that presents a 
barrier for hydrophilic molecules trying to enter the cell. The outer membrane (OM) is even more 
hydrophobic than a typical phospholipid membrane due to the presence of lipopolysaccharides 
(LPS), whose strong lateral interactions inhibit the passage of a variety of compounds through 
the OM6. Translocation across the OM is thus mainly governed by the presence of outer 
membrane protein “porins” that form water-filled channels allowing the diffusion of compounds 
through the OM.  
 
Consequently, the down-regulation of these porins enables bacteria to escape the deleterious 
effects of antibiotics6-9. For example, a reduction in the expression of Outer membrane protein F 
(OmpF), a major porin found in Escherichia coli, has been associated with a decrease in the 
accumulation of fluoroquinolone antibiotics; this eventually gives rise to drug resistance7,10-12. 
Furthermore, antibiotic therapy results in a switch in porin expression from OmpF to the narrower 
OmpC; this is thought to be due to the high osmolarity conditions existing in patients under drug 
treatment7. This leads to a significant decrease in antibiotic accumulation within the cell, and 
hence a decrease in antibiotic susceptibility7. It is thus clear that understanding antibiotic 
accumulation in cells is crucial, and methods to better quantify antibiotic permeation are urgently 
required13. 
 
Fluoroquinolones are broad-spectrum antibiotics that inhibit bacterial type II topoisomerases. 
These topoisomerases are essential enzymes, involved in key cellular processes such as DNA 
replication14. Since their targets are intracellular, fluoroquinolones must pass through the outer 
and inner bacterial membrane to be effective10. The OM thus presents the initial diffusion barrier 
for drug uptake, and the accumulation of fluoroquinolone molecules in the periplasm ultimately 
determines their flux into the cytoplasm. Changes in bacterial susceptibility to fluoroquinolones 
due to changes in pH have been reported previously15,16. An increase in external pH from acidic 
to basic was shown to correspond to a reduction in the minimum inhibitory concentration (MIC) of 
norfloxacin17. Further, it was proposed that this pH mediated change in susceptibility is related to 
changes in the uptake of fluoroquinolones due to alterations of the electric charge of the antibiotic 
molecule18,19; norfloxacin, for example, is positively charged at pH 5 and neutral (zwitterionic, but 
a significant proportion are also uncharged) at pH 718,19. It thus seems reasonable to assume that 
the fluoroquinolone susceptibility of bacteria in response to pH changes is a complicated process, 
which might involve both changes in porin expression20 and changes in drug transport through 
porins in the OM as well as through the phospholipid inner membrane. 
 
At acidic pH values, fluoroquinolone molecules carry charge18 and thus transport across the OM 
should be strongly influenced by even relatively small potentials across the OM. Donnan 
potentials are known to exist across the OM due to the presence of anchored, anionic membrane-
derived oligosaccharides (MDOs) in the E. coli periplasm21,22. The magnitude of these potentials 
depends strongly on the ionic concentration of the surrounding medium. At physiological ion 
concentrations, the Donnan potential is of the order of 20-30 mV, but variations of 5-100 mV have 
been reported by changing external cation concentrations21. One would expect such changes to 
have a significant effect on the transport of charged molecules through OM porins. 
 
For autofluorescent antibiotics like quinolones, the determination of antibiotic uptake via a cell 
ensemble recording has previously been suggested. However, the technique suffers from 
difficulties in distinguishing between antibiotic molecules that were accumulated inside versus 
those bound to the cell membrane23. More recently, fluorescence based single cell imaging 
enabled the comparison of fleroxacin uptake in resistant versus susceptible bacteria24. However, 
barring these few exceptions, a quantitative analysis of fluoroquinolone transport through porins 
and lipids has proven technologically challenging.  
 
In this study we describe an optofluidic assay that measures the permeability of antibiotics through 
porins exclusively in a proteoliposome system. OmpF porins are reconstituted into giant 
unilamellar vesicles and norfloxacin uptake into these proteoliposomes is tracked directly in a 
label-free manner using the UV autofluorescence of the drug. Patching the proteoliposomes 
reveals an estimate of the porin density, and combining the two measurements enables the 
calculation of norfloxacin translocation rates through OmpF channels in the proteoliposomes. 
Furthermore, proteoliposomes are cell-free systems, and thus active or passive uptake processes 
can be independently examined in highly controlled environments. We compare our 
measurements with single channel electrophysiology, and explore the combined effect of pH and 
transmembrane voltage on norfloxacin transport through OmpF.  
 
Results 
Optofluidic Permeability Assay 
 
Figure 1. Optofluidic permeability assay (depicted schematically in Figure 3) shows the rapid uptake of norfloxacin in OmpF 
embedded proteoliposomes. Comparison of the uptake measurements in liposomes and proteoliposomes at pH 5 (a and b) and 
pH 7 (d and e). Each point references an uptake measurement at the single vesicle level, the grey points being t = 0 and the green 
(pH 5) and red (pH 7) being the final detection point t = tf. On average it took individual vesicles about 7.5 s to move from the 
initial to the final detection point. In the absence of porins (a,d), there is no shift in I values observed at the later time point at 
either pH. The presence of porins (b,e) leads to a marked downward shift in I for the majority of the proteoliposomes at the later 
detection point, both at pH 5 and pH 7. The downward shift in I corresponds to an increase in the norfloxacin autofluorescence 
intensity within the proteoliposome (Iin), and is thus a direct measure of norfloxacin uptake. Scatter plots of other porin 
experiments are presented in the Supplementary Information. The histograms (c,f) are a record of permeability coefficients (P) 
measured for individual porin-embedded proteoliposomes, and summarise the data from 3 separate experiments at each pH. 
Histograms from the control measurements with liposomes (no porins) are overlaid to show the shift in P due to the presence of 
porins in the membrane. Total liposomes/proteoliposomes detected were N = 268 (pH 5, with porins), N = 74 (pH 5, no porins), N 
= 420 (pH 7, with porins) and N = 74 (pH 7, no porins). 
In the optofluidic permeability assay, OmpF embedded proteoliposomes (see Methods) are 
exposed to norfloxacin by controlled mixing in a T junction microfluidic chip. The vesicles 
(liposomes/proteoliposomes) are imaged under UV irradiation at two points, first immediately post 
mixing with the drug and then again after time t, a short distance further downstream. A 
comparison of the drug UV autofluorescence intensities within the vesicles at both points enables 
the direct visualisation of drug uptake and the calculation of the permeability coefficient (P) and 
flux (J) of the drug through the vesicle membrane. This assay also allows the comparison of 
norfloxacin flux values through OmpF at different pH conditions in the absence of an applied 
transmembrane voltage. 
The results of the optofluidic permeability assay are summarised in Figure 1 – more results can 
be viewed in the Supplementary Information Figure S1. The graphs (Figures 1 a,b,d,e) show a 
normalised intensity difference (I = {(Iout – Iin)/Iout}) between the background autofluorescence 
intensity (Iout) and the autofluorescence intensity inside the vesicle (Iin), versus vesicle radius (R). 
Each point represents a single vesicle measurement. The grey squares represent vesicles at the 
initial viewpoint immediately post mixing with the norfloxacin (which for convenience we set to t = 
0). The green triangles (pH 5) and red circles (pH 7) represent vesicles once they have travelled 
along the channel to the next detection position. The Permeability Coefficient (P) is given by25: 
𝑃 =  − (
𝑅
3𝑡
) × ln (∆𝐼(𝑡) − ∆𝐼(0) + 1) 
where t is the time taken for the vesicle to move from the initial detection point to the final detection 
point (on average this was about 7.5 s).The norfloxacin concentration present in the channel after 
mixing is about 1 mM; at t = 0, there is no norfloxacin inside the vesicles, whereas outside the 
vesicles the concentration is 1 mM. 
The experiments were performed at pH 5 and pH 7. In both cases the presence of OmpF causes 
a marked change in I indicating the rapid accumulation of the drug inside the proteoliposomes.  
Control measurements in the absence of OmpF revealed a substantially slower uptake, indicating 
that OmpF porins significantly enhance the permeability of the membranes to norfloxacin. We can 
calculate the contributions to the flux from the porins and lipids separately; details are given in the 
Supplementary Information. In the absence of porins, norfloxacin permeability is significantly 
higher at pH 7 than at pH 525. In contrast, the presence of the porins leads to similar permeability 
coefficients at both pH 5 and pH 7. On average, the norfloxacin permeability increased 
approximately 50-fold (pH 5) and 6-fold (pH 7) due to the presence of OmpF in the membrane, 
leading to drug accumulation within the proteoliposomes in a matter of seconds rather than in 
minutes. The relative pH independence of the permeability in the presence of OmpF suggests 
that the charge of the molecule does not play a significant role in influencing its transport through 
the porin in the absence of a transmembrane potential. 
The spread in the permeability coefficient histograms (Figure 1 c,f) is caused by the inevitable 
variability of OmpF insertions into individual vesicles prepared for the optofluidics experiments. 
This can be seen in the scatter plots as well – it is clear that, at both pH conditions, a handful of 
vesicles do not show significant transport. It is known, however, that electroformation produces 
some multilamellar vesicles26, and in these the porins cannot insert across all membranes; this 
accounts for the few negative observations.  
Antibiotic interaction with OmpF using Single channel electrophysiology 
In this assay, electrophysiology was used to study the interaction of norfloxacin with OmpF 
channels reconstituted in planar lipid bilayers. Traditionally, a lipid bilayer is formed across an 
aperture in a Teflon film that separates two reservoirs in a cuvette. The reservoirs are filled with 
an electrolyte solution and a potential difference is applied across the lipid membrane via 
electrodes in the reservoirs. Porins are reconstituted in the lipid bilayer and their conductance 
properties studied by measuring the ionic current flowing through the membrane. The addition of 
antibiotics leads to blockages in the ionic current, since the antibiotic molecules displace ions 
flowing through the porin. A detailed description of the technique is provided in the Methods 
section. 
We varied the transmembrane voltages (25 mV and 50 mV) to determine whether the charge on 
the norfloxacin molecule at pH 5 influenced its transport through the channel under an applied 
electric field comparable to the OM potentials in natural systems. In the absence of antibiotics, 
fluctuations in the ionic current through a single OmpF channel were negligible, both at pH 7 and 
pH 5 (Figures 2a and 2c). The addition of 250 µM norfloxacin to the extracellular (cis) side of the 
protein at pH 7 led to well resolved blockages of ionic current as shown in Figure 2b. 
 
 Figure 2. Ionic current traces of a single trimeric OmpF porin: (a) in the absence of antibiotics at pH 7, (b) with 250 M norfloxacin 
cis side at pH 7, (c) in the absence of antibiotics at pH 5 and (d) with 250 M norfloxacin cis side at pH 5. Electrolyte conditions: 1 
M KCl, 5 mM acetate (pH 5) or 5 mM PO4 (pH 7). The applied voltage was -25 mV. The dotted lines specify the ionic current levels 
through single monomers of the OmpF trimer. The addition of norfloxacin at pH 7 (b) leads to well resolved blockages of the ionic 
current through a monomer, whereas at pH 5 (d) the antibiotic molecules lead to flickering in the ionic current through a monomer 
– full blockages are not always observed. This is due to the low residence time of the antibiotic in the channel at pH 5, as discussed 
in the text.   
At pH 5, the addition of 250 M norfloxacin gave rise to partial unresolved flickering in the ionic 
current (Figure 2d); the ionic current through a monomer was not completely blocked due to the 
presence of the antibiotic. This was due to the low residence times of the norfloxacin molecules 
in the channel at pH 5, as discussed below.  
The kinetic rate constants (association and dissociation rates) characterising the interaction of 
norfloxacin molecules with the OmpF channel were calculated as described previously27; these 
are quantified in Table 1. Interestingly, the dissociation rate of the antibiotic varied by an order of 
magnitude at the different pH conditions. At pH 7 the residence time of the antibiotic in the channel 
was about 900 µs (-25 mV experiments). However at pH 5, when the molecule is positively 
charged, this is reduced to 40 µs (Table 1). This imbalance in the pH 7 and pH 5 residence times 
was observed at the higher transmembrane voltage of -50 mV as well (650 s and 40 s 
respectively).  
The flux (J molecules/s) of norfloxacin through the channel was calculated based on a flux model 
valid for both symmetric and asymmetric transport through a channel27-30. When a transmembrane 
voltage of -25 mV was applied across the bilayer, the flux was found to be slightly higher at pH 5 
(~ 2 molecules/s) than at pH 7 (~ 1 molecule/s). When the transmembrane voltage was increased 
to -50 mV, the norfloxacin flux value at pH 5 increased to 5 ± 1 molecules/s while the flux at pH 7 
remained unchanged (1 molecule/s). An obvious explanation suggests that the positive charge 
on the norfloxacin molecules at pH 5 results in them being driven through the porin under an 
applied transmembrane voltage. At pH 7 the overall charge on the molecule is neutral and thus 
the effect of the transmembrane voltage on the flux seems less important; free diffusion appears 
to be the primary driving agent. However, there might still be some small voltage dependent 
effects since a significant proportion of the molecules are zwitterionic at pH 7 – this requires further 
investigation.  
Note that the flux was calculated using c = 1 mM, to compare with the optofluidic permeability 
assay results described above. This is justified since it was observed that the number of antibiotic 
events in the ionic current recordings increased linearly with an increasing concentration of the 
antibiotic, and hence the rate constants measured with a concentration difference of 250 M were 
equally applicable at a concentration difference of 1 mM. 
Discussion 
In this study, we used a label-free optofluidic permeability assay alongside single channel 
electrophysiology to explore the pH and voltage dependence of norfloxacin transport through 
OmpF porins. The optofluidic assay directly proves that the uptake of norfloxacin is enhanced by 
OmpF reconstituted in the proteoliposomes.  
An interesting pattern emerges: in the absence of any transmembrane potential, the optofluidics 
assay shows that the permeability of the proteoliposomes is essentially the same (within error) at 
both pH 5 and pH 7. However, as the transmembrane voltage is increased (in electrophysiology), 
the flux at pH 5 starts to increase over the flux at pH 7. At a transmembrane voltage close to 
typical physiological OM Donnan potentials21 of -25 mV, the flux at pH 5 is twice as large as the 
flux at pH 7. On increasing the transmembrane voltage to -50 mV, the flux at pH 5 increases to 
five times that at pH 7. This confirms that the positive charge on norfloxacin at pH 5 contributes 
significantly to its transport across porins in the presence of transmembrane voltages. 
It has been reported that a change in the pH from acidic to basic reduced the minimum inhibitory 
concentration (MIC) of norfloxacin17; furthermore, the antibiotic showed maximum cytoplasmic 
accumulation at pH 7.518. This agrees well with the data obtained in our study. As mentioned 
above, our experiments suggest that norfloxacin will likely accumulate in the periplasm (across 
the porin) of an E. coli bacterium at a 2× faster rate at pH 5 compared to pH 7. However, the drug 
molecules now encounter the phospholipid inner membrane (IM). Our previous work showed that 
the direct diffusion of norfloxacin through a pure vesicle lipid bilayer is more effective (by a factor 
of approximately 6×) at pH 7 than at pH 525. Furthermore, the periplasmic pH is expected to be 
the same as the external pH31. Considering the relative rates of norfloxacin transport across the 
two membranes at pH 5 and pH 7 thus explains the higher cytoplasmic accumulation at 
neutral/slightly basic pH values17,18. This suggests that diffusion through the inner membrane 
might present the rate limiting step. However, it should also be noted that medium acidification 
leads to the preferential expression of the narrower OmpC porins over OmpF20 in E. coli, which 
might further reduce norfloxacin accumulation at acidic pH values.  
The optofluidics assay clearly proves that the presence of OmpF makes the resultant 
proteoliposomes more permeable to norfloxacin, with an increased flux of drug molecules through 
the proteoliposome membrane (the total flux through the membrane is given by J = P×4R2×c). 
However, to estimate the flux per porin is not straightforward, since it is difficult to quantify the 
exact number of porins in each proteoliposome membrane. 
To obtain a rough estimate of the flux per porin from the optofluidics assay, vesicles incubated 
with OmpF were patched and characterised electrically using a Port-a-Patch system (Nanion 
Technologies GmbH, Germany) (Supplementary Figure S2). Since the patched area is well-
known (patch diameter = 1 m) and the number of porin insertions counted (using the ionic current 
characteristics, details in Methods), this calibration measurement established a [porin]:[lipid 
surface area] ratio for the vesicles. Electrophysiology can be used to quantify the number of 
functional porins in the membrane which, as far as we know, is not possible with any other 
technique. However, the OmpF concentrations used for this calibration had to be much lower than 
the concentration used in the optofluidics assay, since higher porin concentrations prevented the 
formation of stable patches. Our results yielded an estimate of ~1800 porins per m2 for the 
proteoliposomes used in the optofluidics assay (Supplementary Figure S2). It is interesting to 
compare this result to the estimated number of general diffusion porins found in a typical bacterial 
cell; these porins are found in excess of 105 copies per cell6. This translates into an approximately 
6-7× higher [porin]:[lipid surface area] ratio than used in our experiments. We noted significant 
variability in the OmpF insertion efficiency amongst different vesicle batches for the Port-a-Patch 
characterisation. We believe this is also the underlying reason for the spread in the permeability 
coefficients obtained in the optofluidics experiments (Figure 1 c,f).  
Using the Port-a-Patch calibration, we can estimate the total number of functional porins in each 
proteoliposome detected in the optofluidics assay, and hence can estimate the norfloxacin flux 
per porin for each proteoliposome.  An average over all the proteoliposomes detected gives a 
norfloxacin flux value per porin of 10 ± 8 molecules/s (N=420) at pH 7 and 15 ± 10 molecules/s 
(N=268) at pH 5 (errors are Standard Deviations). Full details of the calculation are provided in 
the Supplementary Information. The errors are a direct consequence of the above mentioned 
variability in OmpF insertion, as seen in the Supplementary Information Figure S2. If we include 
a correction (details in Supplementary Information) to account for the contribution of flux across 
the pure lipids25, the change in the final result is negligible, as expected considering the timescales 
of the measurement and the relatively slower transport through pure DPhPC lipids25. 
These flux per porin values are based on the assumption that the OmpF insertion efficiency 
remains the same even at the higher OmpF concentrations used in the optofluidics assay. In 
support of this assumption, we observed a linear increase in OmpF insertions with OmpF 
concentration in the calibration measurements at low OmpF concentrations (Supplementary 
Figure S2). However, we cannot rule out aggregation effects, which may reduce the insertion 
efficiency at high OmpF concentrations. This could result in fewer functional porins in the 
proteoliposome membranes in the optofluidics assay. This implies that we are possibly 
underestimating the flux per porin and thus our results present a lower bound for this value.  
Our analysis of norfloxacin transport through porins and lipids has thus clarified some of the 
mechanisms by which drug transport is affected under changing external conditions. The 
optofluidics assay also presents a direct visualisation of norfloxacin uptake across a 
proteoliposome membrane in a microfluidic, label-free system, not previously possible. The 
results unambiguously confirm the importance of these porins in facilitating the transport of 
fluoroquinolone antibiotics across the bacterial OM. In addition, our optofluidic technique enables 
the measurement of contributions to diffusion from pure lipids25 and through porins, which cannot 
be done in a quantitative manner using the established liposome swelling assays7,32,33. 
Furthermore, our microfluidic based approach has the potential to explore a wide range of porins. 
Proteoliposomes could be devised containing a combination of passive diffusion porins and active 
transporters, to study competition between these processes. New vesicle preparation 
techniques34 have shown considerable promise for integration into lab-on-a-chip devices and for 
the production of more homogeneous vesicle populations which should translate into better 
control over porin insertions and proteoliposome modification. A combination of traditional and 
advanced single vesicle techniques can thus be used to investigate a variety of drug transport 
phenomena, an urgent need in medicine today.  
 
Methods 
Optofluidic Permeability Assay 
 
Figure 3. Schematic of the optofluidic permeability assay. Control experiments (no porin) are represented in a) and proteoliposome 
experiments (containing OmpF) in b). Vesicles (liposomes/proteoliposomes) are mixed with norfloxacin in a T junction microfluidic 
chip by applying suction at the outlet reservoir with a syringe pump; norfloxacin autofluorescence is stimulated with a UV 
epifluorescence microscope. The vesicles are detected at an initial time ti immediately post mixing and at a later time tf, a distance 
of 7.4 mm further downstream. Vesicles took, on average, about 7.5 s to travel the intervening distance. Both time points are 
observed in the same field of view. Detection of the autofluorescence intensities within the vesicles at both points enables the 
calculation of the drug permeability coefficient for each vesicle. 
The optofluidic permeability assay builds on our previous work studying the Permeability 
Coefficient of norfloxacin across lipid membranes25. It was designed to explore properties of porin 
mediated transport not accessible to electrophysiology and other traditional techniques. It enables 
the study of drug transport through porins without the application of a transmembrane voltage. 
Furthermore, even though electrophysiology has been the method of choice for characterising 
antibiotic-porin interactions at the single molecule level35-38, it suffers from an inability to 
distinguish molecules that translocate through the porin from molecules that simply bind 
transiently27. The optofluidic permeability assay visualises drug transport directly, by observing 
the drug molecules themselves via their autofluorescence; it is thus label-free. Liposome swelling 
assays32,33 were previously used as an alternative to electrophysiology. However, these measure 
antibiotic flux relative to the flux of a permeable sugar (generally arabinose) and hence cannot 
measure drug permeability directly. Furthermore, the diffusion of charged compounds in these 
assays is influenced by the build-up of Donnan potentials inside the liposomes, which can lead to 
unexpected osmotic behaviour32. Our assay overcomes many of these intrinsic limitations and 
provides a new technique for studies of drug transport with porins. 
 
As described in Figure 3, the optofluidic permeability assay involves a T junction microfluidic chip 
where the vesicles (liposomes/proteoliposomes) and the drug molecules are mixed in a channel 
(via the application of suction at the outlet). The T junction geometry of the chip leads to an equal 
mixing of vesicle and drug solutions. The inlet norfloxacin concentration is 2 mM (prepared in the 
same buffer solution as the vesicles) and hence the vesicles are exposed to a final norfloxacin 
concentration of 1 mM. The vesicles are imaged immediately post mixing with the norfloxacin and 
at a distance 7.4 mm further along the channel; the chip was designed such that both points were 
observed in the same field of view (Figure 3). The chip design was based on preliminary 
experiments which showed that a distance of about 7-8 mm between the two points was optimal 
for the detection of proteoliposomes showing increased uptake of the drug.   
The norfloxacin molecules were tracked by stimulating their autofluorescence in the UV25. We 
performed all the optofluidics experiments described in this paper on a commercial Olympus IX73 
microscope, using a DAPI filter set (Chroma) and a Mercury arc lamp (Prior Lumen 200). A 60× 
air objective was used (Olympus LUCPlanFLN, NA 0.70). Images were recorded using a scientific 
CMOS camera (optiMOS, QImaging) which enabled recording at 100 fps (10 ms exposure, bin 
4). The microfluidic flows were controlled using a neMESYS syringe pump with a 250 l Duran 
Borosilicate glass syringe (ILS, Germany) connected to the outlet. At the beginning of the 
experiments, a flow of 30-40 l/hr was applied until the autofluorescence intensity in the 
microfluidic channel reached its peak, ensuring an appropriate drug concentration in the channel. 
Once this level was reached, the flow was slowed to 3 l/hr enabling the detection of individual 
vesicles for multiple frames as desired25.      
The images were recorded using Micromanager 1.439 and analysed in MATLAB (scripts available 
on request) to obtain information about the autofluorescence intensities within the vesicles, in 
addition to the background intensity, vesicle shape and velocity25. Upchurch 1520 G tubing (inner 
diameter 0.03 inch) was used to connect the outlet of the chip to the syringe. Full details of the 
mathematical model and permeability coefficient calculations can be found in the earlier paper25. 
Calculations of the flux are presented in the Supplementary Information document. 
Microfluidic Chip Fabrication 
The microfabrication of the fluidic chip relies on photolithography and replica molding. For the 
fabrication of the mold, a Silicon substrate was covered with a thin layer of adhesion promoter 
(Omnicoat, Microchem, spin coating: 2,000 r.p.m., 30 sec). A layer of SU-8 2025 (Microchem) 
was then deposited (2,000 r.p.m., 30 s), pre-baked (2 min at 65 °C, 5 min at 95 °C) and selectively 
exposed to ultraviolet light (12 s, 365-405 nm, 20 mWcm-2) through a bespoke pellicle mask 
(Photodata Ltd, CAD file available on request). The sample was post-baked (1 min at 65 °C, 3 
min at 95 °C), developed for 3 min, dried with a gentle stream of Nitrogen and hard baked for 5 
min at 95 °C. 
Sylgard 184 polydimethylsiloxane (PDMS) was used to create a negative replica from the Silicon 
mold using standard soft lithography techniques40 with an elastomer:curing agent ratio of 9:1 (Dow 
Corning). The PDMS mixture was poured onto the Silicon mold and baked at 60 °C for 55 minutes. 
The PDMS chip was then peeled off the mold and inlet/outlet columns created using a 1.5 mm 
biopsy punch (Miltex). The chip was plasma bonded to a glass coverslip (Type I, Assistent, 
Germany) using an air plasma (10 W, 25 sccm, 10 s exposure, Diener Electronic GmbH & Co. 
KG, Germany). Post plasma bonding, the chip was left in an oven at 60 °C for 5-10 minutes to 
enhance the adhesion of PDMS to glass.    
Vesicle formation and OmpF incubation 
Giant Unilamellar Vesicles (GUVs) of 1,2-diphytanoyl-sn-glycero-3-phosphocholine (DPhPC) 
lipids (Avanti Polar Lipids) were prepared via electroformation using a Nanion Vesicle Prep Pro 
(Nanion Technologies GmbH, Germany) setup as described previously25. The GUVs were 
prepared in 200 mM Sucrose with 5 mM Phosphate Buffer (pH 7) or 5 mM Acetic Acid (pH 5).  
The OmpF incubation followed previously established protocols41. Purified stock OmpF (5.5 
mg/ml) in a detergent, a 1% solution of n-Octylpolyoxyethylene (octyl-POE, Bachem) prepared in 
Milipore water, was diluted 1:1 in the same detergent and vortexed; 1 l of this freshly diluted 
OmpF solution was added to 199 l of the vesicle stock solution and incubated at room 
temperature for an hour. Biobeads® SM-2 (Bio-Rad) were added to remove the detergent and the 
mixture was incubated at room temperature for 45-60 minutes followed by storage at 4 °C 
overnight. The next day, the OmpF embedded proteoliposome solution was separated from the 
Biobeads with a pipette and the sample used directly in experiments. For the control (liposome) 
experiments, 1 l of 1% octyl-POE (instead of the OmpF solution) was added to 199 l of the 
vesicles; the rest of the incubation protocol remained unchanged.  
Single OmpF porin ionic current measurements in a solvent-free lipid bilayer 
Reconstitution experiments and noise analyses were performed as described in detail 
previously42. The Montal and Mueller technique43 was used to form a phospholipid bilayer using 
DPhPC (Avanti polar lipids). A Teflon film comprising an aperture of approximately 30-60 µm in 
diameter was placed between the two chambers of a cuvette. The aperture was pre-painted with 
1% hexadecane in hexane for stable bilayer formation. 1 M KCl in 5 mM potassium acetate (pH 
5) or 5 mM phosphate (pH 7) was used as the electrolyte solution and added to both sides of the 
chamber. Ionic currents were detected using standard silver-silver chloride electrodes from WPI 
(World Precision Instruments) that were inserted in both sides of the cuvette. Single channel 
measurements were performed by adding the protein to the cis side of the chamber (the side 
connected to the ground electrode). Spontaneous channel insertion was typically obtained while 
stirring the solution in the cuvette under an applied transmembrane voltage. After a successful 
single channel reconstitution, the cis side of the chamber was carefully perfused to remove any 
remaining porins, thus preventing further channel insertions. Conductance measurements were 
performed using an Axopatch 200B amplifier (Molecular Devices) in voltage clamp mode. Signals 
were filtered by an on-board low pass Bessel filter at 10 kHz with a sampling frequency of 50 kHz. 
Amplitude, probability and noise analyses were performed using OriginPro 8 (OriginLab) and 
Clampfit software (Molecular Devices). Single channel analysis was used to determine the 
antibiotic binding kinetics. In a single channel measurement, the quantities measured were the 
duration of blocked levels/residence times (τc) and the frequency of blockage events (ν). The 
association rate constant kon was derived using the number of blockage events, kon = ν/3[c], where 
[c] is the concentration of the antibiotic. The dissociation rate constant (koff) was determined by 
averaging the 1/τc values recorded over the entire concentration range38. 
 
Port-a-Patch calibration for estimating the OmpF porin concentration in proteoliposomes  
The Port-a-Patch calibration measurement involves patching OmpF embedded proteoliposomes 
and counting the number of OmpF porins in a patch using electrophysiology. This measurement 
reveals the number of OmpF porins per unit area on the surface of the proteoliposomes.  
Planar lipid bilayers were obtained from proteoliposomes prepared using the same protocols 
described earlier. Purified stock OmpF (5.5 mg/ml) porins in 1% octyl-POE were diluted in the 
detergent and reconstituted into GUVs by incubating the porins as described previously; however, 
the final porin concentrations used in the Port-a-Patch calibration experiments were a factor of 
500×, 250× and 100× more dilute than the final concentration used in the optofluidics assay to 
enable the counting of single porin insertions in the ionic current traces. After incubation, the 
detergent was removed using Biobeads® SM-2 (Bio-Rad) as described previously. The Biobeads 
were discarded after centrifugation and the protein containing GUVs (proteoliposomes) used 
immediately. 
For the formation of a planar lipid bilayer containing the proteins, 5 µl of the proteoliposome 
solution was pipetted into 5 µl of the electrolyte solution (200 mM KCl, 5 mM acetic acid for pH 5 
or 5 mM phosphate for pH 7). The resulting solution was placed on a microstructured glass chip 
(grounded side) containing an aperture approximately 1 µm in diameter. The vesicles burst once 
they touch the glass surface of the chip thus forming a planar lipid bilayer; additional suction was 
applied to patch proteoliposomes across the aperture. Ionic current measurements were 
performed using the same equipment and software as for the black lipid membrane 
measurements described above. The number of OmpF porins in a patch is calculated from the 
ionic current of the patch (Supplementary Figure S2), since the conductance of a single OmpF 
channel is known (the conductance of the OmpF trimeric porin is 0.9 ± 0.1 nS in 200 mM KCl at 
pH 7; N=20 individual porins were measured42). In the absence of OmpF porins, the ionic 
conductance of the patch is negligible, the bilayer makes a tight seal across the aperture. This 
difference in ionic current provides the basis for counting the number of porins in a patch. 
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Table 1: Antibiotic association (kon) and dissociation (koff) rate constants obtained by single 
channel measurements for OmpF at pH 5 and pH 7. Electrolyte conditions: 1 M KCl, 5 mM PO4 
(pH 7)/acetate (pH 5). 
kon= ( {No. of events/sec}/ 3*[c] ), koff= (1/residence time) 
J= 
kon
cis .ccis .kon
trans 
(kon
cis +kon
trans )
; Δc=1 mM: valid under koff >>> kon . c 
 
 
Antibiotics 
k
on
cis
  (10
3
 ) {1/(s*M)} k
on
trans
(10
3
 ) {1/(s*M)} k
off
total
 1/(s) 
 
J (molecules/s) 
 
Norfloxacin 
 
-50mV 
 
+50mV 
  
Δc=1 mM 
 
pH 7 
 
13 ± 5 
 
1.3 
 
1561 ± 120 
 
 
1 
 
pH 5 
 
11 ± 3 
 
10 
 
25000 
 
 
5 ± 1 
 
 
 
-25mV 
 
+25mV 
 
  
 
 
pH 7 
 
9 ± 2.5 
 
1 
 
1150 ± 60 
 
 
0.9 
 
pH 5 
 
3 ± 1 
 
5 ± 2 
 
27000 
 
 
1.8 ± 0.7 
     
  
0 mV (Optofluidics) 
   
 
pH 7 
 
 
 
 
 
 
 
10 ± 8 
 
pH 5 
 
 
 
 
 
  
 
15 ± 10 
Errors are standard deviations.  
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